A guide to Australia's big experiment with biosimilars

INSIDE STORY


Until the 21st century, rheumatoid arthritis (RA) was considered a  hopeless diagnosis for many patients. Over  the past two decades, however, rheumatology has been catapulted to the cutting edge of research into immune-modulating therapies and an increasing number of biological and synthetic disease-modifying antirheumatic drugs (DMARDs) are emerging.

# Tags